BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26633355)

  • 1. Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation.
    Ibi D; Yamada K
    Int J Mol Sci; 2015 Nov; 16(12):28218-29. PubMed ID: 26633355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3.
    Yamada S; Itoh N; Nagai T; Nakai T; Ibi D; Nakajima A; Nabeshima T; Yamada K
    J Neuroinflammation; 2018 Oct; 15(1):295. PubMed ID: 30348171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-3 is a possible mediator of neurodevelopmental impairment due to polyI:C-induced innate immune activation of astrocytes.
    Yamada S; Nagai T; Nakai T; Ibi D; Nakajima A; Yamada K
    Brain Behav Immun; 2014 May; 38():272-82. PubMed ID: 24594387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA Methylation Changes in a Mouse Model of Infection-Mediated Neurodevelopmental Disorders.
    Richetto J; Massart R; Weber-Stadlbauer U; Szyf M; Riva MA; Meyer U
    Biol Psychiatry; 2017 Feb; 81(3):265-276. PubMed ID: 27769567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal stress, nutrition and physical activity: Impact on immune function, CNS development and psychopathology.
    Marques AH; Bjørke-Monsen AL; Teixeira AL; Silverman MN
    Brain Res; 2015 Aug; 1617():28-46. PubMed ID: 25451133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal context-reward associations in an immune-mediated neurodevelopmental mouse model with relevance to schizophrenia.
    Labouesse MA; Langhans W; Meyer U
    Transl Psychiatry; 2015 Sep; 5(9):e637. PubMed ID: 26371765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased RNA editing in maternal immune activation model of neurodevelopmental disease.
    Tsivion-Visbord H; Kopel E; Feiglin A; Sofer T; Barzilay R; Ben-Zur T; Yaron O; Offen D; Levanon EY
    Nat Commun; 2020 Oct; 11(1):5236. PubMed ID: 33067431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal immune activation and subsequent peripubertal stress as a new model of schizophrenia.
    Yoshimi N; Futamura T; Hashimoto K
    Expert Rev Neurother; 2013 Jul; 13(7):747-50. PubMed ID: 23898846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Antibody and ASD: Clinical Data and Animal Models.
    Gata-Garcia A; Diamond B
    Front Immunol; 2019; 10():1129. PubMed ID: 31191521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal immune activation in neurodevelopmental disorders.
    Solek CM; Farooqi N; Verly M; Lim TK; Ruthazer ES
    Dev Dyn; 2018 Apr; 247(4):588-619. PubMed ID: 29226543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perinatal innate immune activation and neuropsychological development].
    Nagai T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):149-54. PubMed ID: 25069250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain changes in a maternal immune activation model of neurodevelopmental brain disorders.
    Bergdolt L; Dunaevsky A
    Prog Neurobiol; 2019 Apr; 175():1-19. PubMed ID: 30590095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental Resilience and Susceptibility to Maternal Immune Activation.
    Meyer U
    Trends Neurosci; 2019 Nov; 42(11):793-806. PubMed ID: 31493924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders.
    Harvey L; Boksa P
    Dev Neurobiol; 2012 Oct; 72(10):1335-48. PubMed ID: 22730147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible serologic biomarker for maternal immune activation-associated neurodevelopmental disorders found in the rat models.
    Oh-Nishi A; Koga K; Maeda T; Suhara T
    Neurosci Res; 2016 Dec; 113():63-70. PubMed ID: 27425770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology-driven neurodevelopmental animal models of schizophrenia.
    Meyer U; Feldon J
    Prog Neurobiol; 2010 Mar; 90(3):285-326. PubMed ID: 19857543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational opportunities in the prenatal immune environment: Promises and limitations of the maternal immune activation model.
    Bauman MD; Van de Water J
    Neurobiol Dis; 2020 Jul; 141():104864. PubMed ID: 32278881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal inflammation and its ramifications on fetal neurodevelopment.
    Kwon HK; Choi GB; Huh JR
    Trends Immunol; 2022 Mar; 43(3):230-244. PubMed ID: 35131181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rodent Model of Anxiety: The Effect of Perinatal Immune Challenges on Gastrointestinal Inflammation and Integrity.
    Hollins SL; Brock L; Barreto R; Harms L; Dunn A; Garcia-Sobrinho P; Bruce J; Dickson PW; Walker MM; Keely S; Hodgson DM
    Neuroimmunomodulation; 2018; 25(3):163-175. PubMed ID: 30415249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
    Winter C; Djodari-Irani A; Sohr R; Morgenstern R; Feldon J; Juckel G; Meyer U
    Int J Neuropsychopharmacol; 2009 May; 12(4):513-24. PubMed ID: 18752727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.